New Study Published In The Lancet Neurology Shows Topamax(R) Provides Sustained Reduction In Monthly Migraine Days For Up To One Year
December 4th, 2007 by adminA new long-term study into migraine prevention published in The Lancet Neurology shows that patients who continued with Topamax(R) (topiramate) for migraine prophylaxis for up to a year experienced a sustained reduction in the number of migraine days per month, with significant associated benefits on quality of life measures. [click link for full article]
More: continued here
Posted in treatment for migraine headaches |